Page last updated: 2024-10-23

bentazone and Neuroleptic Malignant Syndrome

bentazone has been researched along with Neuroleptic Malignant Syndrome in 1 studies

bentazone: RN given refers to parent cpd; structure
bentazone : A benzothiadiazine that is 1H-2,1,3-benzothiadiazin-4(3H)-one 2,2-dioxide substituted by an isopropyl group at position 3.

Neuroleptic Malignant Syndrome: A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, TJ1
Hung, DZ1
Hu, WH1
Yang, DY1
Wu, TC1

Other Studies

1 other study available for bentazone and Neuroleptic Malignant Syndrome

ArticleYear
Acute basagran poisoning mimicking neuroleptic malignant syndrome.
    Human & experimental toxicology, 1999, Volume: 18, Issue:8

    Topics: Adult; Benzothiadiazines; Diagnosis, Differential; Herbicides; Humans; Male; Neuroleptic Malignant S

1999